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Abstract 
Among the 21st century’s major emerging health issues, one of the most critical is the increasing prevalence of 
individuals with comorbidities, or multiple chronic conditions (MCCs), and the myriad challenges this poses for 
public health, healthcare, social services, and other sectors. Given the increasing prevalence of individuals with 
MCCs and the paramount role of MCCs as a healthcare cost driver, in 2008 the U.S. Department of Health and 
Human Services (HHS) launched an initiative to strengthen efforts by the HHS to address the effects of MCCs 
on health status, quality of life, and cost. In this paper, we fi rst provide an overview of the HHS initiative with 
a particular focus on the approach used in developing the initiative’s centerpiece, the HHS Strategic Framework on 
Multiple Chronic Conditions; we next describe progress in implementing one of the framework’s four major goal 
areas (Goal 4) on facilitating research to fi ll knowledge gaps about, and interventions and systems to benefi t, 
individuals with MCCs; and we conclude by suggesting additional potential priorities for research on MCCs. 
Although considerable research on MCCs has been reported over the past decade, the HHS Strategic Frame-
work’s goal on research provides a set of priority areas and a plan for systematically strengthening the evidence 
and information foundation necessary to address the challenges of MCCs in the USA. More broadly, the Strate-
gic Framework provides a roadmap to help improve coordination between HHS operating divisions and enhance 
collaboration with external stakeholders to improve the quality of life for those with MCCs.
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Introduction
Among the 21st century’s major emerging health issues, 
one of the most critical is the increasing prevalence of 
individuals with comorbidities, or multiple chronic con-
ditions (MCCs), and the myriad challenges this poses 
for public health, healthcare, social services, and other 
sectors [1,2]. The construct of comorbidity dates back to 
at least 1970, when Feinstein used the term in address-
ing the functional effects of comorbid conditions on the 
patient and diagnostic implications [3,4]. Since that time, 
discussion of this issue in the literature has expanded 
substantially [5], and has been refl ected by several other 
terms, including multimorbidity [6], co-occurring 
chronic diseases [7], multiple chronic conditions [1,8], 
and other related terms, such as polypathology and plu-
ripathology [9], and medically complex patients [10]. 
While the issues described by Feinstein over 4 decades 
ago remain in force today, comorbidity is now the prin-
cipal driver for healthcare expenditures in the USA [11].
Given the substantial and increasing prevalence of 
individuals with comorbidities (subsequently referred to 
as MCCs) [12,13], and the paramount role of MCCs as 
a healthcare cost driver, in 2008 the U.S. Department 
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of Health and Human Services (HHS) launched an ini-
tiative to strengthen efforts by the HHS to address the 
effects of MCCs on health status, quality of life, and cost 
[14]. In this paper, we fi rst provide an overview of the 
HHS initiative with a particular focus on the approach 
used in developing the initiative’s centerpiece, the HHS 
Strategic Framework on Multiple Chronic Conditions, and its 
vision of optimum health and quality of life for indi-
viduals with MCCs [8]. We next describe progress in 
implementing one of the framework’s four major goal 
areas (Goal 4) on facilitating research to fi ll knowledge 
gaps about, and interventions and systems to benefi t, 
individuals with MCCs. We conclude by suggesting 
additional potential priorities for research on MCCs.
The HHS initiative on MCCs and development of 
the HHS Strategic Framework on MCCs
The HHS initiative on MCCs dates to the fall of 2008, 
when the HHS Assistant Secretary for Health convened 
and charged a departmental workgroup to identify HHS 
options for improving the health of the MCC popula-
tion. Since the workgroup’s creation, nearly all HHS 
operating divisions have been participating. The work-
group’s initial major effort was to identify ongoing HHS 
programs, activities, and initiatives focused on improv-
ing the health of individuals with MCCs. The resulting 
inventory, fi rst released in March 2009, contained more 
than 50 efforts across the HHS directed primarily to the 
healthcare needs of people with two or more chronic 
health conditions. In addition, a series of interagency 
workgroup meetings addressed focal topics and issues, 
such as reducing rehospitalizations and adverse drug 
events in this population. The workgroup also assisted 
the HHS in both health reform and comparative effec-
tiveness research efforts related to MCCs.
It soon became clear to the workgroup that, among 
other benefi cial effects, an HHS departmental level 
strategic framework for improving the health status of 
individuals with MCCs could serve as a comprehen-
sive roadmap for strengthening coordination within the 
HHS and with external stakeholders in implementing 
the considerable work already directed toward MCCs. 
The workgroup considered a variety of approaches to 
the complex set of issues involving MCCs and trans-
forming those issues into a manageable plan. The result 
was the workgroup’s creation of a draft strategic frame-
work consisting of four interdependent major goal areas: 
Goal 1, strengthening the healthcare and public health 
systems; Goal 2, empowering the individual to use self-
care management; Goal 3, equipping care providers 
with tools, information, and other interventions; and 
Goal 4, supporting targeted research about individuals 
with MCCs and effective interventions [15]. Each of the 
goals, in turn, enumerated a set of objectives and strate-
gies to further guide specifi c actions.
The draft framework underwent iterative review 
within the HHS’s major operating divisions, and then, 
because the HHS recognized that stakeholder and 
community involvement would be essential to the 
framework’s successful implementation, in May 2010, 
an HHS notice in the Federal Register invited interested 
parties to review and comment on the draft strategic 
framework and to provide feedback [16]. As a result, the 
HHS received, and the workgroup reviewed, over 250 
comments from the public and stakeholder organizations 
that were carefully considered and used to improve the 
fi nal product. These comments were particularly help-
ful in ensuring inclusion of behavioral concerns (e.g. 
mental illnesses, substance use, and addiction disorders) 
among the spectrum of health conditions the framework 
addressed.
In December 2010, the HHS released the HHS Stra-
tegic Framework on Multiple Chronic Conditions in an open 
conference call with over 400 registered participants. 
Notably, the National Council on Aging, a private sec-
tor partner, participated in the event and committed to 
lead an effort to help implement the Strategic Frame-
work’s second goal on maximizing the use of self-care 
management. The occasion of the HHS’s release of the 
Strategic Framework also was announced through a 
press release that garnered wider attention [17–19].
Since the Strategic Framework’s release in late 2010, 
the HHS has maintained a sustained focus on imple-
menting key elements in each of the four main goals 
[20]. For example, buoyed by the Patient Protection and 
Affordable Care Act, two HHS operating divisions – the 
Centers for Medicare and Medicaid Services (CMS) and 
the Substance Abuse and Mental Health Services – have 
helped to implement Goal 1 by testing new models of 
care coordination and integration for individuals with 
MCCs [21,22]. In support of Goal 2, the Administration 
on Community Living (ACL) has taken steps to help 
bring the Chronic Disease Self-Management Program 
to scale across the USA; to date, ACL-funded states and 
their partners have reached over 164,000 individuals in 
whom MCCs are prevalent with this evidence-based 
program [23]. In addition, as noted above, the National 
Council on Aging offi cially launched the Self-Manage-
ment Alliance, a consortium of health plans, business, 
and pharmaceutical companies, foundations, and federal 
partners which established the goal of integrating self-
management within the healthcare system by 2020 [24].
Helping to advance Goal 3 and with HHS support, 
the National Quality Forum created a measurement 
framework to spur the development of quality measures 
applicable to the MCC population [25], and the Institute 
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surrounding this issue were shared with a broad seg-
ment of healthcare consumers by the AARP through 
its analysis that cited the HHS Strategic Framework and 
included a set of potential options [see reference 31 for 
these options].
Within the HHS, a study sponsored by the Food 
and Drug Administration (FDA) and the Assistant Sec-
retary for Planning and Evaluation used New Drug 
Applications and Biologic License Applications submit-
ted during fi scal year 2010 to examine the question of 
whether individuals with MCCs are being excluded 
from controlled clinical trials [32]. The investigators 
reported that, in this database population, the preva-
lence of several chronic conditions was lower overall 
than that reported in the total population, and that the 
two conditions most commonly excluded were hepatic 
disorder and psychiatric disorder. It also was stated that 
an analysis of the study level inclusion–exclusion criteria 
showed substantial variation in the number of exclusions 
per study by therapeutic indication. Several studies of 
individual chronic conditions had, on average, ten or 
more exclusions. At the same time, however, the inves-
tigators described a litany of methodologic challenges 
within the practical constraints of this study, including, 
for example, that the clinical trials database precluded 
assessing the profi le of potential subjects who are 
screened, but excluded due to MCCs. One implication 
of this study is that subsequent efforts might consider 
additional or alternative research strategies in determin-
ing whether individuals with certain comorbidities are 
being unnecessarily excluded from trials. The FDA is 
currently reviewing the results of the study to guide its 
future policies and procedures in this area.
Objective B and its strategies concentrate on under-
standing the epidemiology of MCCs. In recent years, 
the number of epidemiologic studies that have exam-
ined MCC patterns among national-level population 
samples in the USA has been growing, as the impor-
tance of MCC populations has been realized. Examples 
include the report by Wolff and colleagues on MCCs in 
a 1999 sample of claims data for Medicare benefi ciaries 
[1], a study of mortality rates across patients with MCCs 
among a cohort of US veterans who used the Veterans 
Health Administration services in 1999 and 2001 [33], 
the Robert Wood Johnson Foundation chart book on 
chronic care, which analyzed data from the Household 
Component of the 2006 Medical Expenditure Panel 
Survey [34], the report from the “Faces of Medic-
aid Data Series” that used claims data from 2001 and 
2002 to identify subgroups of Medicaid benefi ciaries for 
targeted clinical services [35], and a study of multimor-
bidity patterns in elderly veterans during 2007–2008 
[36]. Other descriptions of MCCs among individuals 
in the USA have been produced by studies using data 
of Medicine, in conjunction with the HHS, convened 
clinical practice guideline developers and other experts 
to identify options for enhanced incorporation of com-
mon comorbidities in clinical guidelines [26]. As an 
additional example of Goal 3 implementation, in March 
2013, the HHS released an on-line expanded inventory 
of the HHS and private sector-led programs, activi-
ties, and initiatives directed at improving the health of 
individuals with MCCs. The inventory provides basic 
information about 250 such activities that supported 
the Strategic Framework’s goals, objectives, and strate-
gies [27]. Of these, 15 were highlighted in a separate 
Innovative Profi les report that emphasized features such 
as innovative approaches, demonstrable impact, poten-
tial for scalability, or valuable insights and lessons for 
professionals or individuals living with MCCs or their 
caregivers [28]. Finally, several efforts have been under-
taken to implement Goal 4 objectives on enhancing 
research to fi ll knowledge gaps about individuals with 
MCCs as detailed below.
Progress in implementing Goal 4 on research to 
benefi t individuals with MCCs
The Strategic Framework’s Goal 4 focuses on the imper-
ative for research to fi ll knowledge gaps about, and on 
interventions and systems to benefi t, individuals with 
MCCs. This cross-cutting goal reinforces other parts of 
the Strategic Framework that call for improved infor-
mation to better understand MCCs, and for expanding 
the evidence base for preventing and mitigating the 
burden of MCCs. This goal’s overall aim is expressed 
through four objectives that encompass, respectively, 
four domains: (A) increasing the external validity of 
clinical trials; (B) increasing understanding of the basic 
epidemiology of MCCs; (C) increasing research on 
community and patient-centered health outcomes; and 
(D) improving understanding of the roles of disparities 
in MCC populations [8].
Objective A and its strategies focus on the need for 
increasing the external validity of relevant clinical trials, 
especially by assessing the inclusion of individuals with 
MCCs and by reducing the unnecessary exclusion of 
such individuals from clinical trials. Investigators exter-
nal to the HHS who cited to the framework examined 
whether patients with MCCs are under-represented in 
randomized controlled trials that are published in high-
impact journals; they observed that, among the sample 
of reports they studied, few trials in the past 15 years 
included patients with MCCs [29]. Other investigators 
who assessed the inclusion of people with comorbidi-
ties in trials similarly note the limited attention accorded 
to comorbidities in clinical trials [30]. Implications 
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sources in individual states, such as those by Koroukian 
et al. [37] and by Miller et al. [38]. 
To help advance Objective B strategies on basic epi-
demiologic research and on determining MCC patterns 
in Medicare and other populations, the HHS formed an 
MCC data workgroup with experts from three agen-
cies (the Agency for Healthcare Research and Quality 
[AHRQ], Centers for Disease Control [CDC], and 
CMS). This workgroup has conducted coordinated, 
parallel epidemiologic analyses of fi ve national-level data 
sets encompassing populations in a spectrum of settings, 
including the National Health Interview Survey (NHIS) 
[12]; National Ambulatory Medical Care Survey [39]; 
Medical Expenditure Panel Survey [40]; Nationwide 
Inpatient Sample of the Healthcare Cost and Utilization 
Project [41]; and Medicare benefi ciary enrollment and 
claims administrative data [42]. Reports on these analy-
ses have been published together in Preventing Chronic 
Disease [43], along with reports on a conceptual model 
for standardizing approaches to defi ning, identifying, 
and using information about chronic conditions in the 
USA [44], and on a study of NHIS data to characterize 
co-occurring leading lifestyle-related chronic condi-
tions among adults [13].
In addition to the coordinated analyses of fi ve HHS 
data systems, since the Strategic Framework’s release in 
2010, several other HHS research studies, reports, and 
information resources on MCCs have been made public. 
These include an analysis of NHIS data to compare esti-
mates of MCC occurrence among adults aged 45 years or 
older during two periods of time, 1999–2000 and 2009–
2010 [45]; and the CMS 2011 and 2012 chart books on 
chronic conditions among Medicare fee-for-service 
benefi ciaries with a dominant emphasis on MCC preva-
lence, associated healthcare utilization, and costs in 2008 
and 2010, respectively [11,46]. The CMS also recently 
released two public-use data resources for researchers 
and others, including data on state level MCC preva-
lence, healthcare utilization, and costs among Medicare 
benefi ciaries [47], and an interactive data dashboard 
allowing for examination of state- and hospital refer-
ral region (HRR)-level MCC patterns among Medicare 
benefi ciaries [48–51]. The release of the public-use 
data resource on state-level MCC patterns was also fol-
lowed by preparation of a report for publication [52]. In 
addition, the AHRQ reported fi ndings of a study that 
focused on healthcare access and expenditures among 
non-elderly adults with MCCs by insurance coverage 
status during 2007–2008 [53]. 
Objective C and its strategies target increased clinical, 
community, and patient-centered research. MCC-related 
research initiatives supported by the National Institutes 
of Health (NIH) have supported several strategies under 
this objective. For example, during 2010–2013, the NIH 
announced these and other funding opportunities to 
foster extramural research about MCCs:
 • The fi rst, Notice number NOT-OD-11-020 (Decem-
ber 2010), addressed the need for more effective 
behavioral treatments for patients with MCCs, and 
encouraged investigators to address more effective 
research methods and measures for conceptualiz-
ing, triaging, and assessing the health behavior (e.g. 
adherence, mental health problems, diet and exercise, 
and substance use/abuse disorders) of patients with 
MCCs [54].
 • The second, Funding Opportunity Announcement 
(FOA) Number PA-12-024 (November 2011), sought 
proposals to use a common conceptual model to 
develop behavioral interventions – using a common 
approach rather than behavior-specifi c interventions 
and/or condition-specifi c interventions – to improve 
health outcomes in patients with MCCs. Specifi -
cally, this announcement offered support for research 
in primary care that uses a multidisease-care man-
agement approach to behavioral interventions with 
high potential impact to improve patient-level health 
outcomes for individuals with three or more chronic 
health conditions [55].
 • The third, FOA Number RFA-AG-13-003 ( July 
2012), supported secondary analyses of data sets aimed 
at: assessing the public health and health-cost impact 
of specifi c combinations of MCCs in defi ned older 
populations; identifying differences in effectiveness 
and safety of different treatment regimens for patients 
with specifi c combinations of MCCs; examining 
alterations in safety or effectiveness of a treatment 
for one condition related to the presence of one or 
more specifi c coexisting conditions; and addressing 
methodologic issues relevant to analyses of the health 
impact or treatment of MCCs [56].
 • The fourth, FOA PA-13-168 (March 2013), also sup-
ported secondary analyses of data sets, with research 
objectives including effects of specifi c combinations 
of two or more comorbid conditions or combina-
tions of medications on risks for specifi c benefi cial 
and/or adverse health outcomes; public health and 
cost impact of specifi c combinations of two or more 
chronic conditions; differences in health outcomes 
between alternative treatment regimens or healthcare 
management strategies for older patients with specifi c 
combinations of two or more chronic conditions; and 
interactions among medications, disease processes, 
and health outcomes in complex older patients with 
MCCs [57]. 
 • The fi fth, RFA RM-13-012 (August 2013), sought 
applications for demonstration projects across two 
or more healthcare systems for effi cient, large-scale 
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pragmatic clinical trials focused on management of 
patients with MCCs [58]. 
Several other HHS developments are helping to fur-
ther the Objective C focus on clinical, community, and 
patient-centered research that elucidates the evidence 
base for preventing and treating individuals with MCCs. 
For example, the AHRQ created the “MCC Research 
Network” to foster improved understanding about inter-
ventions that provide the greatest benefi t to MCC patients 
[59]. The network includes 45 grantees with fund-
ing to advance the fi eld of MCC research with focuses 
on comparative effectiveness, quality improvement, and 
patient-centered outcomes research. In addition, a meeting 
convened jointly in early 2013 by AHRQ, NIH, and the 
Patient-Centered Outcomes Research Institute (PCORI) 
examined the context of health in individuals with MCCs. 
The meeting’s key long-term goal – to enhance the inclu-
sion of contextual factors in research on MCCs – was 
addressed by exploring key contextual factors and relevant 
research methods, and developing a research agenda [60; 
Stange KC: personal communication]. 
Objective D and its strategies address disparities in 
MCC populations, including stimulating and using 
research about the roles of disparities in MCC popu-
lations that would assist in focusing intervention. 
The HHS’s principal research effort on disparities in 
MCC populations is a study supported by the Offi ce 
of the Assistant Secretary for Planning and Evalu-
ation that aims to describe data systems and data sets 
that can be analyzed to better improve understanding 
of and approaches to addressing disparities in MCC 
populations. This effort especially focuses on describ-
ing MCC combinations that are most important for 
targeting interventions.
Conclusion
Although considerable research on MCCs has been 
reported over the past decade, the HHS Strategic Frame-
work provides a set of priority areas and a plan for 
systematically strengthening the evidence and informa-
tion foundation necessary to address the challenges of 
MCCs in the USA. In the relatively short period since 
the Strategic Framework was released, HHS agencies and 
programs have used the framework to guide new research 
initiatives on MCCs. As a result, and as refl ected in this 
report, HHS programs have pursued a broad spectrum 
of MCC research activities addressing priority areas by, 
for example, examining the inclusion (or exclusion) of 
comorbidities in clinical trials; conducting epidemiologic 
research and reporting fi ndings on MCC occurrence 
in representative national-level population samples in 
diverse settings; supporting studies to improve the quality 
and effectiveness of medical management of individuals 
with MCCs; and increasing understanding of the effects 
of disparities in MCC populations. 
In addition to research efforts that are already com-
pleted or still in progress, the HHS Initiative on MCCs 
and its derivative Strategic Framework have helped to 
highlight other priority focus areas for research. Among 
these priorities are needs for developing the following:
 • Better data on, identifi cation, and characterization 
of combinations of comorbidities that are preva-
lent, account disproportionately for suffering and 
healthcare expenditures, and are most amenable 
to interventions – this priority would extend work 
already in progress by refi ning identifi cation of the 
most important dyads, triads, and other combinations 
of comorbidities from the standpoint of amenability 
to prevention, management, and mitigation.
 • Expanded local-level (i.e. subnational level) data on 
MCCs – building on the concept of the CMS’s pub-
licly available dashboard with state- and HRR-level 
data – for use in health-policy making, planning, ser-
vice delivery, and program evaluation. 
 • More data tailored to special uses, such as helping to 
better inform the development of clinical practice 
guidelines by addressing comorbidities to guidelines’ 
index conditions [61–64].
Substantial efforts are being made nationally to 
improve the health and quality of life for individu-
als with MCCs. Signifi cant gaps exist in the optimal 
approach to care, and these are beginning to be addressed 
through the research directions articulated in the Strate-
gic Framework. More broadly, the Strategic Framework 
provides a roadmap to help improve coordination 
between HHS operating divisions and enhance collabo-
ration with external stakeholders to improve the quality 
of life for those with MCCs. Now is the time to view 
person-centered chronic disease prevention and care 
management through the prism of MCCs.
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